The rapid acceptance of hemp farming has created tremendous opportunities across many industries, including research, agriculture, manufacturing, production, fabrication, construction, and pharmaceuticals. We are seeing the re-emergence of hemp fiber applications as a highly regenerative and synergistic building material from centuries past and creating new approaches with carbon farming to reduce greenhouse emissions. While the USDA specifically legalized industrial hemp having a THC limit of 0.3%, the consequence by default seemingly made resin-type CBD hemp also legal, and the preferred crop since it can comply with the definition. The evidence is readily apparent by the cornucopia of CBD-laden products in the marketplace despite the lack of any FDA opinion to date on their regulatory status. Quality standards should require hemp-derived ingredients destined for human consumption to meet the same standards as any other food product, witth minimum testing for biological, chemical, and physical contaminants. The impact of weeds and plant pathogens, including insects, often tempts growers to apply pesticides currently unregistered for use on hemp or other crops destined for human consumption. The use of unregistered pesticides on hemp creates a route for human exposure to inconsistently regulated chemicals. Without question, regulation lays ahead for the resin hemp CBD industry. Additional pressure from fermentation-derived cannabinoids produced at a fraction of the cost, combined with strained relations from the state-regulated, yet federally illegal, drug-type THC industry, adds to the challenge for hemp farmers. The success of the legal hemp industry will hopefully serve as persuasion for the federal rescheduling of drug-type THC cannabis as well.